Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M.

Dr. Kavya reveals 6 subtle signs your liver may be struggling, from persistent fatigue to belly fat. Don’t ignore these ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Gastroenterologist shares a simple matcha chia pudding recipe packed with antioxidants and fiber to naturally boost liver ...

NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

The following is a summary of “Aggregate index of systemic inflammation tied to increased fatty liver disease risk: insights ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has ...